Michelle C Turner, Urszula Radzikowska, Denisa E Ferastraoaru, Mariona Pascal, Pieter Wesseling, Alexandra McCraw, Claudine Backes, Heather J Bax, Christoph Bergmann, Rodolfo Bianchini, Luigi Cari, Leticia de Las Vecillas, Elena Izquierdo, Frida Lind-Holm Mogensen, Alessandro Michelucci, Petr V Nazarov, Simone P Niclou, Giuseppe Nocentini, Markus Ollert, Matthias Preusser, Nataliya Rohr-Udilova, Andrea Scafidi, Reka Toth, Mieke Van Hemelrijck, Michael Weller, Uta Jappe, Maria M Escribese, Erika Jensen-Jarolim, Sophia N Karagiannis, Aurélie Poli
Epidemiological studies have explored the relationship between allergic diseases and cancer risk or prognosis in AllergoOncology. Some studies suggest an inverse association, but uncertainties remain, including in IgE-mediated diseases and glioma. Allergic disease stems from a Th2-biased immune response to allergens in predisposed atopic individuals. Allergic disorders vary in phenotype, genotype and endotype, affecting their pathophysiology. Beyond clinical manifestation and commonly used clinical markers, there is ongoing research to identify novel biomarkers for allergy diagnosis, monitoring, severity assessment and treatment...
January 24, 2024: Allergy